What Researchers Did
The researchers used ultrasound to look at blood flow at the back of the brain in 32 people with sudden hearing loss, and compared hearing levels with those findings before treatment, after 10 days, and after 3 months.
What They Found
In a case-control study of 32 patients with sudden sensorineural hearing loss treated with pentoxifylline infusions, patients with normal transcranial Doppler findings improved by an average of 17 dB, while those with abnormal findings improved less. Thirteen patients had normal findings, eight had borderline findings, and six had pathologic findings. Average hearing improvement was 3 dB in the borderline group and 0 dB in the pathologic group. In five patients, the initially pathologic findings improved during therapy, and these patients had the greatest average hearing improvement, 28 dB. The abstract reports that patients with hearing loss had more frequent pathologic findings than a normal population.
What This Means for Canadian Patients
The abstract does not address hyperbaric oxygen therapy. It covers only pentoxifylline treatment and ultrasound of blood flow in sudden hearing loss. The authors suggest that blood-vessel problems may play a role in some patients and that ultrasound might help guide treatment choice, but they note the number of patients is small.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was small, with only 32 patients and no randomised comparison of treatments, so the authors describe their conclusions as applying to at least some patients.